273 related articles for article (PubMed ID: 1325289)
1. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
Weckbecker G; Liu R; Tolcsvai L; Bruns C
Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
[TBL] [Abstract][Full Text] [Related]
2. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Weckbecker G; Raulf F; Bodmer D; Bruns C
Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Pinski J; Reile H; Halmos G; Groot K; Schally AV
Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
6. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism.
Viguerie N; Tahiri-Jouti N; Ayral AM; Cambillau C; Scemama JL; Bastié MJ; Knuhtsen S; Estève JP; Pradayrol L; Susini C
Endocrinology; 1989 Feb; 124(2):1017-25. PubMed ID: 2563240
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide].
Wang CH; Tang CW
Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891
[TBL] [Abstract][Full Text] [Related]
8. SMS 201.995 inhibits in vitro and in vivo growth of human colon cancer.
Dy DY; Whitehead RH; Morris DL
Cancer Res; 1992 Feb; 52(4):917-23. PubMed ID: 1737355
[TBL] [Abstract][Full Text] [Related]
9. Desensitization and resensitization of rat pituitary tumor cells in long-term culture to the effects of the somatostatin analogue SMS 201-995 on cell growth and prolactin secretion.
Koper JW; Hofland LJ; van Koetsveld PM; den Holder F; Lamberts SW
Cancer Res; 1990 Oct; 50(19):6238-42. PubMed ID: 2169342
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of human gastric cancer metastasis by ocreotide in vitro and in vivo].
Wang C; Tang C
Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):19-22. PubMed ID: 11953120
[TBL] [Abstract][Full Text] [Related]
11. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
Fitzpatrick SL; LaChance MP; Schultz GS
Cancer Res; 1984 Aug; 44(8):3442-7. PubMed ID: 6331647
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
Arteaga CL; Osborne CK
Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
Wang C; Tang C; Tang L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer.
Foekens JA; Portengen H; van Putten WL; Trapman AM; Reubi JC; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Dec; 49(24 Pt 1):7002-9. PubMed ID: 2555057
[TBL] [Abstract][Full Text] [Related]
15. Characterization of somatostatin receptors on human neuroblastoma tumors.
O'Dorisio MS; Chen F; O'Dorisio TM; Wray D; Qualman SJ
Cell Growth Differ; 1994 Jan; 5(1):1-8. PubMed ID: 8123588
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
18. Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice.
Murayama Y
Ann Surg; 1990 Mar; 211(3):263-8. PubMed ID: 2155590
[TBL] [Abstract][Full Text] [Related]
19. Octreotide inhibits growth factor-induced and basal proliferation of lens epithelial cells in vitro.
Baldysiak-Figiel A; Jong-Hesse YD; Lang GK; Lang GE
J Cataract Refract Surg; 2005 May; 31(5):1059-64. PubMed ID: 15975478
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
